Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Longevity Capital is a private investment platform focused on the longevity industry rather than a drug-development biotech company. The business offers direct investment opportunities, tradable certificates, and investment funds targeting longevity-related companies, and it positions itself as Deep Knowledge Group's investment platform. Its strategy is built around data-driven selection of portfolio companies using comparative analytics and industry intelligence supplied by Aging Analytics Agency. Based on available public information, the firm operates as an active commercial investment manager and capital formation platform for longevity, preventive medicine, regenerative medicine, and precision medicine opportunities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longevity Capital.